What is the trade name for flibanserin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trade Name for Flibanserin

The trade name for flibanserin is ADDYI®. 1

Product Details

  • ADDYI (flibanserin) is manufactured and distributed by Sprout Pharmaceuticals, Inc., based in Raleigh, NC, USA 1

  • The medication is available as 100 mg oval, pink, film-coated tablets debossed with "f100" on one side 1

  • ADDYI received FDA approval in August 2015 for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women 2, 1, 3

Clinical Context

  • ADDYI is dosed as 100 mg once daily at bedtime, and this bedtime-only dosing is critical due to the risk of hypotension and syncope if taken during waking hours 1

  • The medication is contraindicated with alcohol consumption and moderate or strong CYP3A4 inhibitors due to severe risks of hypotension and loss of consciousness 1

  • ADDYI demonstrates modest efficacy, resulting in approximately 1 additional satisfying sexual event every 2 months compared to placebo in premenopausal women with HSDD 2, 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Options for Women with Low Libido and Difficulty Achieving Orgasm

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Flibanserin Efficacy and Safety in Premenopausal Women with HSDD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.